IFCC committee on markers for bone turnover and bone disease - project presentation

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 57, Issue 227, 1997, Pages 95-99

  Woloszczuk, W ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; OSTEOCALCIN; BIOLOGICAL MARKER;

BONE DISEASE; BONE TURNOVER; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STANDARDIZATION; TECHNIQUE; BONE; INFORMATION PROCESSING; METABOLISM; REFERENCE VALUE; REVIEW;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DISEASES; FOCUS GROUPS; HUMANS; REFERENCE VALUES;

EID: 0030629116     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709168314     Document Type: Conference Paper

References (11)

1. Kent N. Pyridinoline/Desoxypyridinoline. Scand J Clin Lab Invest 1997;57 (Suppl 227):73-79.
2. Robins SP, Duncan A, Wilson A, Evans LE. Standardization of the Pyridinium Crosslinks, Pyridinoline and Deoxypyridinoline, for Use as Biochemical Markers of Collagen Degradation. Clin Chem 1996;42:1621-1626.
3. Vermeers C. Production of Well Defined Homogenous Osteocalcin Standards. Scand J Clin Lab Invest 1997:57 (Suppl 227):10-104
4. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest1993; 91:1769-74.
5. Garnero P, Grimeaux M, Seguin P. Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9: 225-64.
6. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino. Serum Propeptide and Intact Molecular Osteocalcin in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker of Bone Growth and Response to GH Therapy:. J Clin Endocrinol Metab 1992;75:1104-1109.
7. Sokol IJ, O'Brien ME, Camilo ME, Sadowski JA. Undercarboxylated Osteocalcin and Development of a Method to Determine Vitamin K Status. Clin Chem 1995;41/8;1121-8.
8. Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J. Decreases Serum Osteocalcin Levels in Phenprocoumon-Treated Patients. J Clin Endocrinol Metab 1988; 66:1071-4.
9. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla Protein (Osteocalcin) Assay Standardization Report. J Bone Miner Res. 1990;5:5-11.
10. Hertz HS. Development of an International Directory of Reference Methods and Reference Materials. Eur J Clin Chem Clin Biochem 1995;33:999-1002.
11. Joffe P, Heaf JG, Hyldstrup L. Osteocalcin: A noninvasive index of metabolic bone disease in patients treated by CAPD. Kidney Int, 1994;46:838-846.